Author:
Benoni G.,Cuzzolin L.,Zambreri D.,Caramazza I.,Soldato P.,Caliceti P.,Conforti A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Toxicology,Pharmacology,Immunology
Reference6 articles.
1. S. D. Hewitt, R. C. Hider, P. Sarpong, C. J. Morris and D. R. Blake,Investigation of the anti-inflammatory properties of hydroxypyridinones. Ann. Rheum. Dis.48, 382–388 (1989).
2. R. Schleyerbach and H. Wedde,Alterations in the gastrointestinal functions during the development of adjuvant disease in rats. Agents and Actions15, 392–397 (1984).
3. J. J. Bullen,The significance of iron in infection. Rev. Infect. Dis.3, 1127–1138 (1981).
4. B. G. Veilleux and I. Rowland,Simulation of the rat intestinal ecosystem using a two-stage continuous culture system. J. Gen. Microbiol.123, 103–115 (1981).
5. J. Y. Jeremy, M. A. Barradas, G. Kontoghiorghes and P. Dandona,The iron chelators desferrioxamine and 1,2-dimethyl-3-hydroxypyridone inhibit human platelet cyclooxygenase and lipoxygenase activity. Br. J. Pharmacol.95, 690P (1988).